financetom
Business
financetom
/
Business
/
Acadia Pharmaceuticals Terminates COO Brendan Teehan
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Acadia Pharmaceuticals Terminates COO Brendan Teehan
Nov 20, 2024 7:32 PM

05:21 PM EST, 11/20/2024 (MT Newswires) -- Acadia Pharmaceuticals ( ACAD ) said in a late Wednesday filing that Chief Operating Officer Brendan Teehan will be involuntarily terminated without cause, effective immediately.

Chief Executive Catherine Adams will assume responsibilities of the COO role until a successor is appointed, the company said.

Teehan will remain with the company as a non-executive employee until Dec. 31, the company added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2025 - www.financetom.com All Rights Reserved